AMRZ Form 4: CFO Purchases 10,500 Shares at ~$47.7, Raises Stake
Rhea-AI Filing Summary
Ian A. Johnston, identified as Chief Financial Officer, executed multiple purchases totaling 10,500 ordinary shares of Amrize Ltd on 08/08/2025 at prices between $47.66 and $47.75 per share. The reported transactions raised his beneficial ownership to 17,344 ordinary shares. The Form 4 lists only non-derivative purchases in separate lots and shows no derivative holdings reported.
Positive
- Insider purchases totaling 10,500 ordinary shares at prices between $47.66 and $47.75
- Reported beneficial ownership increased to 17,344 ordinary shares, showing higher insider stake
Negative
- None.
Insights
TL;DR: Multiple insider buys totaling 10,500 shares at about $47.7 raise the CFO's stake to 17,344, a signaling event but not clearly material alone.
The transaction record documents a series of purchases executed on 08/08/2025, with per-share prices ranging $47.66–$47.75. Aggregate insider purchases of 10,500 shares can be interpreted as a positive disclosure signal from management; however, without company market-cap or outstanding share count in this filing, the absolute materiality for investors is unclear. No options, warrants, or other derivative instruments were reported.
TL;DR: Form 4 shows compliant, itemized reporting of multiple ordinary-share purchases by the CFO; disclosure appears complete for non-derivative activity.
The filing provides line-item detail for each lot purchased and the cumulative beneficial ownership following the trades. The report identifies the reporting person as Chief Financial Officer and documents only purchases of ordinary shares. From a governance and disclosure perspective, the Form 4 fulfills Section 16 reporting of insider acquisitions; there are no amendments, derivative positions, or denial-of-filing indicators present in the text provided.
FAQ
Who reported the trades for Amrize (AMRZ)?
How many shares did the Amrize (AMRZ) insider buy?
At what prices were the Amrize (AMRZ) shares purchased?
What is the reporting person’s total beneficial ownership after these transactions?
Were any derivative securities reported in the Amrize (AMRZ) Form 4?